Comprehensive Analysis of Genomic and Phenomic Data Reveals Context-Dependent Function of A20 (TNFAIP3) in Renal Cell

Nour Abu Jayab1,2, Burcu Yener1,3, Reem Sami Alhamidi1

  • 1Research Institute of Medical and Health Sciences, University of Sharjah, Sharjah P.O. Box 27272, United Arab Emirates.

Cancers
|June 12, 2026
PubMed
Abstract

Insights

A20 (TNFAIP3) shows increased expression in clear-cell renal cell carcinoma (ccRCC) and influences cell behavior differently depending on the cell type. This suggests A20 has context-dependent roles in ccRCC progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • A20 (TNFAIP3) is a negative regulator of NF-κB signaling with known context-dependent roles in cancer.
  • The specific function of A20 in renal cell carcinoma (RCC), especially clear-cell RCC (ccRCC), is not fully understood.

Purpose of the Study:

  • To investigate the role and impact of A20/TNFAIP3 in ccRCC.
  • To analyze the transcriptional and genomic alterations associated with A20 expression in ccRCC.

Main Methods:

  • Analysis of public transcriptomic data (GEO) from ccRCC and control samples.
  • Functional assays and transcriptomic profiling of A20-overexpressing cell lines (HEK293, 786-O).
  • DNA sequencing and survival analysis using patient data (TCGA-KIRC).

Main Results:

  • Significant upregulation of TNFAIP3/A20 was observed in ccRCC, correlating with NF-κB pathway enrichment.
  • A20 overexpression induced distinct cellular phenotypes, including altered apoptosis, proliferation, and migration in a cell-context-dependent manner.
  • A20-high ccRCC samples showed enrichment of pathways involved in NF-κB signaling, TGF-β, DNA repair, metabolism, hypoxia, and proteasome function. Genomic analysis revealed alterations in NF-κB-related genes.

Conclusions:

  • A20/TNFAIP3 exhibits context-dependent effects in RCC, influencing tumor-relevant pathways.
  • A20 expression is associated with significant transcriptional and genomic alterations in ccRCC that warrant further investigation.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...